M&A

  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to acquire Penumbra for $14.5B

    With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

    By • Jan. 15, 2026
  • A birds-eye picture of a stethoscope and piggy bank against a blue background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Digital health funding increases in 2025, spurred by AI: report

    Startups raised $14.2 billion last year, the highest funding total since 2022. Health AI companies collected 54% of total funding, according to Rock Health.

    By Emily Olsen • Jan. 15, 2026
  • Three stacked wooden cubes on the right side of the frame read "M&A"
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Smith & Nephew to acquire Integrity Orthopaedics for up to $450M

    The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.

    By • Jan. 14, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy incontinence device maker Valencia

    The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.

    By • Jan. 12, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards calls off JenaValve buyout after court halts deal

    Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

    By • Jan. 12, 2026
  • An image of a medical device with a white and blue handle, a metal rod and a circular tip.
    Image attribution tooltip
    Permission granted by Haemonetics
    Image attribution tooltip

    Haemonetics to acquire Vivasure Medical

    The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

    By • Jan. 9, 2026
  • Two people view Medtronic's Hugo robotic surgery system in an operating room.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip
    Deep Dive

    4 medtech topics to watch in 2026

    From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in 2026.

    By • Jan. 8, 2026
  • A doctor examines a patient's eyes using a light and a microscope.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    STAAR shareholders reject Alcon’s revised buyout offer

    The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion offer.

    By • Jan. 6, 2026
  • An illustration of DNA against a blue abstract background
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Natera acquires Foresight Diagnostics for up to $450M

    Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.

    By • Dec. 10, 2025
  • Two business people signing a contract
    Image attribution tooltip
    simarik via Getty Images
    Image attribution tooltip

    Teleflex inks deals to sell 3 businesses for $2B

    Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.”

    By • Dec. 10, 2025
  • A warehouse with rows of packages
    Image attribution tooltip
    Courtesy of Medline
    Image attribution tooltip

    PitchBook: AI tuck-in deals to drive M&A acceleration in 2026

    Buyers will focus on “tuck-ins that add AI or data-driven capabilities or can meaningfully improve scale against emerging competitors,” the analysts said.

    By • Dec. 3, 2025
  • A person stands in front of the screen of a machine on wheels, near a sign that says "GE HealthCare"
    Image attribution tooltip
    Stringer via Getty Images
    Image attribution tooltip

    GE HealthCare to buy Intelerad for $2.3B

    GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal expands GE HealthCare’s presence in more outpatient settings.

    By • Nov. 21, 2025
  • M&A due diligence lawyers legal
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Solventum inks $725M Acera takeover

    The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

    By • Nov. 21, 2025
  • Senior Research Associate Tanya Quint loads one of the instruments used to run Exact Sciences' Cologuard test at the company's headquarters in Madison, Wis. (Photo: Business Wire)
    Image attribution tooltip
    Courtesy of Business Wire/Exact Sciences
    Image attribution tooltip

    Abbott’s $21B Exact Sciences buy reveals future strategy

    The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing. 

    By • Nov. 21, 2025
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott to acquire Exact Sciences for about $21B

    The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.

    By , • Updated Nov. 20, 2025
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp inks deal to buy Parkview Health outreach laboratory assets

    The takeover extends a string of deals that have consolidated the outreach lab services market.

    By • Nov. 14, 2025
  • The Federal Trade Commission emblem on the Constitution Center in Washington, D.C.
    Image attribution tooltip
    Laurel Deppen/MedTech Dive
    Image attribution tooltip

    Judge denies FTC’s bid to block $627M Surmodics buyout

    The ruling removes a barrier to a deal the FTC claims will eliminate competition in the outsourced hydrophilic coatings market.

    By • Nov. 12, 2025
  • Two business people are signing contract.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Laborie inks $465M deal to buy post-childbirth device from Organon

    Organon tripled sales of the bleeding-control system from 2022 to 2024 and is on track to grow sales again this year.

    By • Nov. 10, 2025
  • Qiagen
    Image attribution tooltip
    Courtesy of Qiagen
    Image attribution tooltip

    Qiagen inks $225M single-cell buyout as CEO prepares to step down

    Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

    By • Nov. 5, 2025
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher to acquire clinical trial data firm Clario for $8.9B

    The purchase is expected to complement Thermo’s clinical research services as companies are conducting more trials.

    By • Oct. 29, 2025
  • A patient and clinician in front of a Hologic breast imaging device
    Image attribution tooltip
    Courtesy of Hologic
    Image attribution tooltip

    Hologic to go private for up to $18.3B

    Funds managed by Blackstone and TPG plan to acquire the medtech firm for up to $79 per share.

    By • Oct. 21, 2025
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific to buy Nalu Medical for $533M

    Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.

    By • Oct. 17, 2025
  • The Johnson & Johnson logo is displayed at company offices on October 17, 2023, in Irvine, California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    What J&J’s ortho spinoff means for the industry

    Analysts expect that DePuy Synthes could become a stronger competitor as a standalone company.

    By • Oct. 16, 2025
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J plans to spin out orthopedics business

    CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such as cardiovascular and robotics.

    By • Oct. 14, 2025
  • Two business people signing a contract
    Image attribution tooltip
    simarik via Getty Images
    Image attribution tooltip

    Owens & Minor inks $375M deal to sell unit to investment firm

    The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that provides products directly to patients.

    By • Oct. 8, 2025